Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 176

Results For "Pan"

9190 News Found

Abbott study shows continuous glucose monitoring outperforms fingersticks in Type 2 diabetes
Clinical Trials | March 16, 2026

Abbott study shows continuous glucose monitoring outperforms fingersticks in Type 2 diabetes

This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin


Dr. Jitendra Singh lays Foundation for Rs 600 crore  Orchid Bio-Pharma plant in Kathua
News | March 16, 2026

Dr. Jitendra Singh lays Foundation for Rs 600 crore Orchid Bio-Pharma plant in Kathua

The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics


China’s NMPA approves Zydus-licensed anaemia drug Desidustat
News | March 15, 2026

China’s NMPA approves Zydus-licensed anaemia drug Desidustat

Desidustat tablets are a novel oral HIF-PHI approved for treating anaemia in non-dialysis adult CKD patients


Almirall opens Shanghai hub to power dermatology innovation and China partnerships
Biopharma | March 14, 2026

Almirall opens Shanghai hub to power dermatology innovation and China partnerships

The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development


GelMEDIX partners with Catalent to advance vision-restoring cell therapies
News | March 14, 2026

GelMEDIX partners with Catalent to advance vision-restoring cell therapies

The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing


BioNTech co-founders launch new mRNA venture, aiming to revolutionize next-gen therapies
News | March 14, 2026

BioNTech co-founders launch new mRNA venture, aiming to revolutionize next-gen therapies

The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission


Lilly issues urgent warning over potentially dangerous Tirzepatide-B12 compounds
News | March 14, 2026

Lilly issues urgent warning over potentially dangerous Tirzepatide-B12 compounds

Lilly has long voiced concerns over mass-compounded knockoffs of its tirzepatide medicines, Mounjaro and Zepbound


Gesynta Pharma launches Phase 2 trial of promising Endometriosis drug
Clinical Trials | March 14, 2026

Gesynta Pharma launches Phase 2 trial of promising Endometriosis drug

The trial’s primary goal is to evaluate vipoglanstat’s effect on endometriosis-related pain during non-menstrual days


Biogen unveils promising new data for Salanersen in kids with SMA
News | March 14, 2026

Biogen unveils promising new data for Salanersen in kids with SMA

Salanersen was generally well-tolerated, slowed neurodegeneration, and enabled functional gains